Accordingly, BC is stratified into four subtypes: Luminal A, Luminal B, HER2(+) and triple negative BC (TNBC) that present discrepancies in overall survival (OS) and disease‐free period (DFP) (Table 1). This evidence concerns the gene ERBB2 and breast cancer.